Apricus Biosciences Inc. (APRI:NASDAQ) Annual Reports & Investor Relations Material

Overview

Apricus Biosciences, Inc. is a pharmaceutical company that specializes in designing and developing pharmaceutical products. They have a subsidiary, Bio-Quant, Inc., that provides pre-clinical contract research organization services. The company uses their patented NexACT drug delivery technology to create pharmaceutical products.

Annual Reports

Frequently Asked Questions

What is Apricus Biosciences Inc.'s ticker?

Apricus Biosciences Inc.'s ticker is APRI

What exchange is Apricus Biosciences Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Apricus Biosciences Inc.'s headquarters?

They are based in San Diego, California

How many employees does Apricus Biosciences Inc. have?

There are 11-50 employees working at Apricus Biosciences Inc.

What is Apricus Biosciences Inc.'s website?

It is http://www.apricusbio.com

What type of sector is Apricus Biosciences Inc.?

Apricus Biosciences Inc. is in the Healthcare sector

What type of industry is Apricus Biosciences Inc.?

Apricus Biosciences Inc. is in the Drug Manufacturers - Other industry

Who are Apricus Biosciences Inc.'s peers and competitors?

The following five companies are Apricus Biosciences Inc.'s industry peers:

- Seagate

- Amneal Pharmaceuticals

- Viatris

- Aphria

- Heron Therapeutics Inc